AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
There are effective ways to optimize your budget based on expenses. Discover techniques that help you manage your finances better.
19,588 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...
Equity futures fell and oil surged as the initial round of U.S.-Iran talks began, setting a tense tone for markets an...
Fomo has closed a $75 million Series B round led by Index Ventures, pushing the company’s valuation to $550 million a...
Wall Street frets over a tech compression cycle even as AI-driven storage demand grows. Seagate Technology positions ...
SpaceX's public debut created big waves, but a recent pullback has many investors asking if it’s time to buy. This ar...
Micron’s stock has surged dramatically in the last year. While some analysts see meaningful upside from current level...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...
Global markets are buzzing as offshore crypto platforms increasingly offer pre-IPO exposure tied to SpaceX rumors. Tr...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
SpaceX has experienced a sharp move after going public, sparking questions about lockups and what it means for future...
Geopolitical tensions around Iran are pushing oil volatility and, in turn, accelerating EV adoption. Analysts warn th...